Product
200- ppm NO
1 clinical trial
1 indication
Indication
nosocomial pneumoniaClinical trial
High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With Cardiopulmonary BypassStatus: Completed, Estimated PCD: 2024-01-15